Japan panel OK’s 2 iPS cell therapies despite little data
Professor Paul Knoepfler, Ph.D.
A Japanese panel voted to move 2 iPS cell therapies forward for approval despite there being minimal clinical trial data. Let's discuss the context and potential risks. The post Japan panel OK’s 2 iPS cell therapies despite little data appeared first on The Niche .